Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physical Conditioning, Animal | 5 | 2024 | 29 | 2.710 |
Why?
|
| Endothelium, Vascular | 6 | 2023 | 17 | 2.400 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2021 | 12 | 1.900 |
Why?
|
| Exercise Therapy | 2 | 2023 | 24 | 1.490 |
Why?
|
| Vasodilation | 4 | 2023 | 7 | 1.260 |
Why?
|
| Coronary Vessels | 2 | 2021 | 27 | 1.240 |
Why?
|
| Atherosclerosis | 2 | 2021 | 16 | 1.240 |
Why?
|
| Alzheimer Disease | 2 | 2021 | 62 | 1.230 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2020 | 40 | 1.190 |
Why?
|
| Inflammasomes | 2 | 2020 | 40 | 1.180 |
Why?
|
| Obesity | 2 | 2020 | 115 | 1.110 |
Why?
|
| Oxidative Stress | 4 | 2021 | 58 | 1.060 |
Why?
|
| Animals | 12 | 2025 | 1711 | 0.850 |
Why?
|
| Metabolic Syndrome | 1 | 2024 | 9 | 0.840 |
Why?
|
| Male | 12 | 2024 | 2491 | 0.840 |
Why?
|
| Nitric Oxide | 3 | 2020 | 11 | 0.840 |
Why?
|
| Poverty | 1 | 2024 | 22 | 0.840 |
Why?
|
| Brachial Artery | 1 | 2023 | 2 | 0.820 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 4 | 0.820 |
Why?
|
| Mice | 10 | 2025 | 685 | 0.820 |
Why?
|
| Inflammation Mediators | 1 | 2023 | 9 | 0.820 |
Why?
|
| Feeding Behavior | 1 | 2024 | 47 | 0.810 |
Why?
|
| Biomarkers | 1 | 2023 | 81 | 0.790 |
Why?
|
| Exercise | 3 | 2024 | 173 | 0.790 |
Why?
|
| Uncoupling Protein 2 | 1 | 2021 | 1 | 0.710 |
Why?
|
| Motor Activity | 2 | 2020 | 61 | 0.700 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 7 | 0.700 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2020 | 2 | 0.650 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 6 | 0.650 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 55 | 0.640 |
Why?
|
| Mesenteric Arteries | 1 | 2018 | 1 | 0.570 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 2 | 0.570 |
Why?
|
| Vascular Diseases | 1 | 2018 | 4 | 0.560 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 17 | 0.550 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 184 | 0.540 |
Why?
|
| Interleukin-6 | 1 | 2017 | 9 | 0.540 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 14 | 0.540 |
Why?
|
| Heart | 1 | 2017 | 48 | 0.520 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 39 | 0.510 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 225 | 0.450 |
Why?
|
| Muscle, Skeletal | 4 | 2025 | 78 | 0.400 |
Why?
|
| Middle Aged | 4 | 2024 | 967 | 0.380 |
Why?
|
| Diet, High-Fat | 3 | 2023 | 34 | 0.350 |
Why?
|
| Inflammation | 2 | 2023 | 57 | 0.330 |
Why?
|
| Arterioles | 2 | 2021 | 4 | 0.320 |
Why?
|
| Diet, Fat-Restricted | 2 | 2020 | 4 | 0.310 |
Why?
|
| Signal Transduction | 2 | 2021 | 216 | 0.280 |
Why?
|
| Humans | 7 | 2024 | 4936 | 0.260 |
Why?
|
| Female | 3 | 2024 | 2523 | 0.250 |
Why?
|
| Aged | 3 | 2023 | 703 | 0.240 |
Why?
|
| Homeostasis | 1 | 2025 | 29 | 0.220 |
Why?
|
| Energy Intake | 1 | 2024 | 10 | 0.210 |
Why?
|
| Prevalence | 1 | 2024 | 66 | 0.210 |
Why?
|
| Monoglycerides | 1 | 2023 | 1 | 0.210 |
Why?
|
| Diet | 1 | 2024 | 40 | 0.210 |
Why?
|
| Fatty Liver | 1 | 2023 | 7 | 0.210 |
Why?
|
| Risk Factors | 1 | 2024 | 159 | 0.200 |
Why?
|
| Recovery of Function | 1 | 2023 | 18 | 0.200 |
Why?
|
| Aging | 1 | 2025 | 109 | 0.200 |
Why?
|
| Cell Phone | 1 | 2023 | 7 | 0.200 |
Why?
|
| Exercise Test | 2 | 2021 | 41 | 0.200 |
Why?
|
| Time Factors | 1 | 2023 | 163 | 0.190 |
Why?
|
| Treatment Outcome | 1 | 2023 | 177 | 0.190 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2020 | 6 | 0.190 |
Why?
|
| Adult | 3 | 2024 | 1567 | 0.190 |
Why?
|
| Resistance Training | 1 | 2022 | 5 | 0.190 |
Why?
|
| Mice, Knockout | 2 | 2025 | 140 | 0.190 |
Why?
|
| Quality of Life | 1 | 2023 | 87 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 37 | 0.180 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2021 | 1 | 0.180 |
Why?
|
| Iridoids | 1 | 2021 | 1 | 0.180 |
Why?
|
| Acetylcholine | 1 | 2021 | 2 | 0.180 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 21 | 0.180 |
Why?
|
| Angiostatins | 1 | 2021 | 1 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 16 | 0.170 |
Why?
|
| Maze Learning | 1 | 2021 | 22 | 0.170 |
Why?
|
| Rats, Wistar | 1 | 2021 | 31 | 0.170 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 15 | 0.170 |
Why?
|
| MicroRNAs | 1 | 2021 | 53 | 0.170 |
Why?
|
| Receptors, Adiponectin | 1 | 2020 | 2 | 0.170 |
Why?
|
| Zonula Occludens-2 Protein | 1 | 2020 | 2 | 0.170 |
Why?
|
| Adiponectin | 1 | 2020 | 3 | 0.170 |
Why?
|
| Superoxides | 1 | 2020 | 5 | 0.170 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2020 | 7 | 0.170 |
Why?
|
| Caspase 1 | 1 | 2020 | 11 | 0.170 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 17 | 0.170 |
Why?
|
| Aorta | 1 | 2020 | 8 | 0.170 |
Why?
|
| Hippocampus | 1 | 2021 | 59 | 0.160 |
Why?
|
| Posterior Cerebral Artery | 1 | 2020 | 2 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 14 | 0.160 |
Why?
|
| RNA, Messenger | 1 | 2020 | 68 | 0.160 |
Why?
|
| Rats | 1 | 2021 | 241 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2020 | 47 | 0.160 |
Why?
|
| Mice, Obese | 1 | 2018 | 9 | 0.140 |
Why?
|
| Brain | 1 | 2020 | 195 | 0.140 |
Why?
|
| Vasomotor System | 1 | 2016 | 1 | 0.120 |
Why?
|
| Radiation Exposure | 1 | 2016 | 2 | 0.120 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2015 | 2 | 0.110 |
Why?
|
| Bicycling | 1 | 2015 | 7 | 0.110 |
Why?
|
| Physical Fitness | 1 | 2015 | 22 | 0.110 |
Why?
|
| PrPC Proteins | 1 | 2025 | 1 | 0.060 |
Why?
|
| Regeneration | 1 | 2025 | 15 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2025 | 71 | 0.050 |
Why?
|
| Mitochondria, Muscle | 1 | 2024 | 1 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2024 | 5 | 0.050 |
Why?
|
| Physical Endurance | 1 | 2024 | 7 | 0.050 |
Why?
|
| Acyltransferases | 1 | 2023 | 2 | 0.050 |
Why?
|
| Antioxidants | 1 | 2024 | 23 | 0.050 |
Why?
|
| Mitochondria | 1 | 2024 | 20 | 0.050 |
Why?
|
| Leukocyte Common Antigens | 1 | 2022 | 3 | 0.050 |
Why?
|
| Cell Count | 1 | 2022 | 34 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 31 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2021 | 4 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 8 | 0.040 |
Why?
|
| Depression | 1 | 2023 | 125 | 0.040 |
Why?
|
| Adolescent | 1 | 2023 | 758 | 0.040 |
Why?
|
| Young Adult | 1 | 2023 | 787 | 0.040 |
Why?
|
| Whole-Body Irradiation | 1 | 2016 | 1 | 0.030 |
Why?
|
| Hindlimb | 1 | 2016 | 4 | 0.030 |
Why?
|
| Xanthine Oxidase | 1 | 2016 | 3 | 0.030 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Arteries | 1 | 2016 | 2 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 3 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 11 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 30 | 0.030 |
Why?
|
| Space Flight | 1 | 2016 | 26 | 0.030 |
Why?
|
| Lactoferrin | 1 | 2015 | 2 | 0.030 |
Why?
|
| alpha-Defensins | 1 | 2015 | 2 | 0.030 |
Why?
|
| Salivary alpha-Amylases | 1 | 2015 | 2 | 0.030 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2015 | 4 | 0.030 |
Why?
|
| Athletes | 1 | 2015 | 8 | 0.030 |
Why?
|
| Saliva | 1 | 2015 | 19 | 0.030 |
Why?
|
| Muramidase | 1 | 2015 | 32 | 0.030 |
Why?
|